Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells
- 1 August 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (3), 375-382
- https://doi.org/10.1016/0006-2952(93)90512-u
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II: evidence for a non-topoisomerase II-mediated mechanism of doxorubicin cytotoxicityBiochemical Pharmacology, 1993
- Abrogation of adriamycin toxicity in vivo by cycloheximideBiochemical Pharmacology, 1992
- Cell death induced by topoisomerase inhibitors: Role of calcium in mammalian cellsBiochemical Pharmacology, 1991
- Cell surface actions of adriamycinPharmacology & Therapeutics, 1991
- Redox chemistry of anthracycline antitumor drugs and use of captodative radicals as tools for its elucidation and controlChemical Research in Toxicology, 1991
- Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermiaBiochemical Pharmacology, 1990
- G2 block induced by DNA crosslinking agents and its possible consequencesBiochemical Pharmacology, 1988
- Adriamycin and daunomycin induce interstrand DNA crosslinks in HeLa S3 cellsBiochemical and Biophysical Research Communications, 1983
- Cell Death: The Significance of ApoptosisInternational Review of Cytology, 1980
- Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline DrugsPublished by S. Karger AG ,1977